Berning, L.; Schlütermann, D.; Friedrich, A.; Berleth, N.; Sun, Y.; Wu, W.; Mendiburo, M.J.; Deitersen, J.; Brass, H.U.C.; Skowron, M.A.;
et al. Prodigiosin Sensitizes Sensitive and Resistant Urothelial Carcinoma Cells to Cisplatin Treatment. Molecules 2021, 26, 1294.
https://doi.org/10.3390/molecules26051294
AMA Style
Berning L, Schlütermann D, Friedrich A, Berleth N, Sun Y, Wu W, Mendiburo MJ, Deitersen J, Brass HUC, Skowron MA,
et al. Prodigiosin Sensitizes Sensitive and Resistant Urothelial Carcinoma Cells to Cisplatin Treatment. Molecules. 2021; 26(5):1294.
https://doi.org/10.3390/molecules26051294
Chicago/Turabian Style
Berning, Lena, David Schlütermann, Annabelle Friedrich, Niklas Berleth, Yadong Sun, Wenxian Wu, María José Mendiburo, Jana Deitersen, Hannah U. C. Brass, Margaretha A. Skowron,
and et al. 2021. "Prodigiosin Sensitizes Sensitive and Resistant Urothelial Carcinoma Cells to Cisplatin Treatment" Molecules 26, no. 5: 1294.
https://doi.org/10.3390/molecules26051294
APA Style
Berning, L., Schlütermann, D., Friedrich, A., Berleth, N., Sun, Y., Wu, W., Mendiburo, M. J., Deitersen, J., Brass, H. U. C., Skowron, M. A., Hoffmann, M. J., Niegisch, G., Pietruszka, J., & Stork, B.
(2021). Prodigiosin Sensitizes Sensitive and Resistant Urothelial Carcinoma Cells to Cisplatin Treatment. Molecules, 26(5), 1294.
https://doi.org/10.3390/molecules26051294